greeksoup/ stock research

Lemaitre Vascular (LMAT) FY2023 results: revenue $193 million, up 19.7% on the year

Lemaitre Vascular Inc. (LMAT) reported revenue of $193 million for fiscal 2023, the year ended 31 December 2023, up 19.7% on the year before. Net income was $30 million, up 45.9%, and diluted earnings per share $1.34. The figures are the company's own, from the 10-K it filed with the SEC on 29 February 2024.

Revenue
$193 million
+19.7% on the year
FY2016FY2023
Operating margin
19.0%
16.6% a year earlier
FY2016FY2023
Net income
$30 million
+45.9% on the year
FY2016FY2023
Diluted EPS
$1.34
+44.1% on the year
FY2016FY2023

this yearthe year beforeHover a bar for its figure.

The year in brief

The four quarters: Q1 FY2023 · Q2 FY2023 · Q3 FY2023 · Q4 FY2023

Income statement (profit and loss)

$ millionFY2023FY2022FY2021On the yearLast 8 years
Revenue193162154+19.7%
Cost of revenue66.456.853.0+17.1%
Gross profit127105101+21.1%
Gross margin65.7%64.9%65.7%
Research and development17.013.311.8+27.6%
Operating income36.726.836.4+36.8%
Operating margin19.0%16.6%23.6%
Interest expense0.00.02.2
Pre-tax income39.527.534.3+43.6%
Income tax9.46.97.4+36.7%
Effective tax rate23.7%24.9%21.5%
Net income30.120.626.9+45.9%
Net margin15.6%12.8%17.4%
Diluted EPS$1.34$0.93$1.25+44.1%
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionFY2023FY2022FY2021On the yearLast 8 years
Operating cash flow36.825.435.1+44.8%
Capital expenditure7.33.24.9+125.0%
Free cash flow29.522.130.2+33.1%
Free cash flow margin15.2%13.7%19.6%
Cash from investing-24.7-10.4-61.1
Cash from financing-7.1-9.213.7
Depreciation and amortisation9.59.411.1+0.9%
Share-based compensation5.34.23.5+27.5%
Buybacks0.90.60.8+32.9%
Dividends paid12.411.09.3+13.3%
Dividend per share$0.56$0.50$0.44+12.0%
Diluted shares, weighted22m22m21m+1.1%

Balance sheet

$ millionFY2023FY2022FY2021On the yearLast 8 years
Shareholders' equity298268254+11.1%
Debt0.00.00.0
Operating lease liabilities16.614.714.1+13.0%
Other liabilities32.327.624.6+17.0%
Total liabilities and equity347310293+11.7%
Fixed assets21.817.917.1+21.5%
Goodwill65.965.965.90.0%
Intangible assets41.746.552.7-10.4%
Investments80.863.656.1+27.1%
Cash and equivalents24.319.113.9+26.8%
Receivables25.122.019.6+13.7%
Other assets87.275.467.5+15.7%
Total assets347310293+11.7%

10-K for the year ended 31 December 2023, filed 29 February 2024: the filing.